Valuation (24%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.66 | N/A |
PEG Ratio (TTM) | 0.00 | N/A |
P/S Ratio (TTM) | 0.21 | N/A |
P/B Ratio (TTM) | -2.50 | N/A |
P/FCF Ratio (TTM) | -2.25 | N/A |
Price to 5YR AVG Earnings Ratio | -2.15 | N/A |
Price to 5YR AVG FCF Ratio | -0.83 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -44.41% | N/A |
ROE (TTM) | -125.36% | N/A |
Net Profit Margin (TTM) | -26.48% | N/A |
ROIC 5YR AVG | -73.45% | N/A |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -832.07% | -23.08% | -52.79% |
Revenue | -10.83% | -3.00% | -7.40% |
Net Income | -170.40% | -57.19% | -79.37% |
Cash Flow | 8.55% | -894.49% | -516.53% |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.65 | N/A |
Quick Ratio (TTM) | 1.20 | N/A |
D/E Ratio (TTM) | -0.10 | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -0.03 | N/A |
Shares Outstanding Growth 5YR AVG | 19.17% | N/A |